Growth Metrics

Amneal Pharmaceuticals (AMRX) Change in Intangibles: 2017-2025

Historic Change in Intangibles for Amneal Pharmaceuticals (AMRX) over the last 5 years, with Sep 2025 value amounting to $7.4 million.

  • Amneal Pharmaceuticals' Change in Intangibles rose 105.94% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year decrease of 61.37%. This contributed to the annual value of $14.7 million for FY2024, which is 34.56% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Change in Intangibles of $7.4 million as of Q3 2025, which was up 723.78% from $900,000 recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Change in Intangibles registered a high of $31.8 million during Q3 2022, and its lowest value of $338,000 during Q1 2023.
  • Over the past 3 years, Amneal Pharmaceuticals' median Change in Intangibles value was $1.1 million (recorded in 2023), while the average stood at $4.5 million.
  • Data for Amneal Pharmaceuticals' Change in Intangibles shows a peak YoY increase of 2,769.82% (in 2024) and a maximum YoY decrease of 96.98% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Amneal Pharmaceuticals' Change in Intangibles stood at $1.2 million in 2021, then soared by 1,900.00% to $31.8 million in 2022, then plummeted by 96.86% to $19.9 million in 2023, then crashed by 96.98% to $600,000 in 2024, then skyrocketed by 105.94% to $7.4 million in 2025.
  • Its Change in Intangibles stands at $7.4 million for Q3 2025, versus $900,000 for Q2 2025 and $4.2 million for Q1 2025.